Position in ALNY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,103,749
-$779,668 QoQ
Shares Held
30,242
+1.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#195
of 764 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. ALNY ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,103,749 | 30,242 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,883,417 | 29,871 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,866,979 | 27,328 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,925,312 | 26,152 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,157,793 | 25,017 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,252,853 | 23,157 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $5,284,121 | 22,456 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,679,369 | 20,650 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,121,468 | 21,076 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,943,866 | 19,698 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,696,775 | 14,089 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,653,666 | 14,984 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,825,357 | 14,875 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $3,372,988 | 16,838 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,963,289 | 16,677 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,867,292 | 14,325 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,086,092 | 14,303 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,250,626 | 13,783 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,271,693 | 13,396 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,527,599 | 13,387 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,324,627 | 13,713 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,702,045 | 12,055 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,569,907 | 12,079 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,742,104 | 11,965 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,751,845 | 11,828 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||